Welcome To Welox Pharma WHO-GMP | ISO 9001:2015
Translated into:
Welcome To Welox Pharma WHO-GMP | ISO 9001:2015
Introduction to Amoxynorm 625 mg:
Amoxynorm 625 mg tablets are a potent combination of Amoxicillin and Potassium Clavulanate. This synergistic antibiotic therapy is designed to combat a broad spectrum of bacterial infections, providing reliable and efficient treatment.
Uses of Amoxynorm 625 mg:
Amoxynorm 625 mg is indicated for:
Respiratory Tract Infections: Effective in treating conditions such as bronchitis, sinusitis, and pneumonia.
Urinary Tract Infections: Manages infections of the urinary tract, including cystitis and pyelonephritis.
Skin and Soft Tissue Infections: Treats cellulitis, wound infections, and abscesses.
Dental Infections: Useful for dental abscesses and other oral infections.
Bone and Joint Infections: Addresses osteomyelitis and septic arthritis.
Benefits of Amoxynorm 625 mg:
Amoxynorm 625 mg offers several benefits:
Broad-Spectrum Action: Effective against a wide range of bacteria, including those resistant to amoxicillin alone.
Enhanced Efficacy: The combination of Amoxicillin and Potassium Clavulanate extends the antibiotic's spectrum and improves treatment outcomes.
Convenient Dosing: Provides a practical dosing regimen for better patient compliance.
Quick Symptom Relief: Alleviates symptoms rapidly, promoting faster recovery.
Mechanism of Action of Amoxynorm 625 mg:
Amoxicillin: A penicillin-class antibiotic that works by inhibiting bacterial cell wall synthesis, leading to cell lysis and death.
Potassium Clavulanate: A beta-lactamase inhibitor that protects amoxicillin from degradation by beta-lactamase enzymes produced by resistant bacteria, thereby extending its antibacterial spectrum.